Marcus (NYSE:MCS) reported quarterly losses of $(0.76) per share which met the analyst consensus estimate. This is a 44.53 percent increase over losses of $(1.37) per share from the same period last year. The company reported quarterly sales of $92.55 million which beat the analyst consensus estimate of $83.53 million by 10.79 percent. This is a 1.44K percent increase over sales of $6.00 million the same period last year.
The Valens’ Green Roads Donates $120K To The Arthritis Foundation, Presents Arthritis Pain Relief CBD Roll-On
Green Roads, a subsidiary of The Valens Company (NASDAQ: VLNS) is an official supporting sponsor of the Arthritis Foundation after giving a $120,000 donation to support the organization's pain management initiative to advance improved quality of life for those living with chronic pain.<
